Zobrazeno 1 - 10
of 147
pro vyhledávání: '"K. Midthun"'
Autor:
W. P. McKinney, K. Midthun, R. D. Clover, C. Heilman, Kristin L Nichol, Jr Snider, J. E. Cheek, D. Bradshaw, L. D. Rotz, H. D. Wilson, C. T. Le, D. A. Brooks, D. A. Ashford, M. B. Rennels, G. Peter, R. E. Jackson, J. Abramson, J. I. Santos, V. Marchessault, L. Pickering, B. M. Word, S. A. Gall, L. S. Tompkins, F. A. Guerra, John F. Modlin, T. R. Graydon, M. Mahoney, J. D. Siegel, C. M. Helms, G. S. Evans, M. G. Myers, D. R. Johnson, B. J. Howe, S. L. Katz, P. Gardner, P. A. Offit, W. Schaffner
Publikováno v:
Journal of Toxicology: Clinical Toxicology. 39:85-100
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3461f65ea2e9ee8c23cb20ee18e22cb
https://doi.org/10.1081/clt-100102886
https://doi.org/10.1081/clt-100102886
Autor:
Mehmet Ceyhan, Edward T. Zito, K Midthun, Güler Kanra, Gülten Seçmeer, Bruce Davidson, Timo Vesikari
Publikováno v:
Acta Paediatrica. 82:223-227
Rhesus-human reassortant tetravalent rotavirus vaccine at a titer of 4 x 10(4) plaque forming units was evaluated for immunogenicity in 194 6-8-week-old breast-fed Turkish infants. The vaccine was administered orally as a single dose following either
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ba4aefc7f1cc386d8cbc306e94f2cb
https://doi.org/10.1111/j.1651-2227.1993.tb12646.x
https://doi.org/10.1111/j.1651-2227.1993.tb12646.x
Autor:
R B Belshe, Raphael Dolin, K Midthun, Mary Lou Clements, Geoffrey J. Gorse, Peter F. Wright, Barney S. Graham, Norbert J. Roberts, Michael C. Keefer, Lawrence Corey
Publikováno v:
Journal of Infectious Diseases. 166:244-252
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) gp160 recombinant vaccinia virus (HIVAC-1e) vaccine was evaluated in vaccinia-naive, healthy adults at low risk for acquiring HIV-1 infection. Volunteers (n = 36) were ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed9c34847dde061ac7b6271e137fca49
https://doi.org/10.1093/infdis/166.2.244
https://doi.org/10.1093/infdis/166.2.244
Autor:
Gary B. Calandra, David R. Nalin, Philip J. Provost, Edward F. Ellerbeck, Audrey E. Rhoad, John A. Lewis, Brenda McGuire, Kenneth Gershman, K Midthun, William J. Miller, Joseph P. Davide, Marcy E. Armstrong
Publikováno v:
Vaccine. 10:668-672
To determine the safety and immunogenicity of an inactivated hepatitis A vaccine, 56 healthy adult volunteers were randomly assigned to receive an intramuscular injection of 6.3, 12.5 or 25 ng of inactivated hepatitis A vaccine or placebo at 0, 2 or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4860bd5a5e959ab54418e5820ce41496
https://doi.org/10.1016/0264-410x(92)90087-z
https://doi.org/10.1016/0264-410x(92)90087-z
Publikováno v:
Developments in biologicals. 116
Preventive vaccines for infectious disease indications are regulated by the Office of Vaccines Research and Review, CBER, FDA. FDA-regulated biological products, including vaccines, must be safe, pure, potent, and manufactured consistently according
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7adb1b1812b421614f067e3bf97a603
https://pubmed.ncbi.nlm.nih.gov/15603184
https://pubmed.ncbi.nlm.nih.gov/15603184
Autor:
M L, Clements-Mann, M K, Makhene, J, Mrukowicz, P F, Wright, Y, Hoshino, K, Midthun, E, Sperber, R, Karron, A Z, Kapikian
Publikováno v:
Vaccine. 17(20-21)
Live rotavirus vaccine candidates representing VP7 serotypes 1, 2, 3 or 4 derived by reassortment between bovine UK rotavirus and human rotavirus strains D, DS-1, P or ST3 were evaluated for safety and immunogenicity in adults, children and infants.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56546180e5670aa45bd382968c7021eb
https://pubmed.ncbi.nlm.nih.gov/10418923
https://pubmed.ncbi.nlm.nih.gov/10418923
Publikováno v:
Developments in biological standardization. 95
The development plan for new combination vaccines should include clinical studies designed to provide an adequate safety database (as well as efficacy data) to support licensure. Ideally, randomized studies to compare the safety of the combination va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e5cf95ee03dabd60e1ca65d88e43f57
https://pubmed.ncbi.nlm.nih.gov/9855438
https://pubmed.ncbi.nlm.nih.gov/9855438
Autor:
B S, Graham, R B, Belshe, M L, Clements, R, Dolin, L, Corey, P F, Wright, G J, Gorse, K, Midthun, M C, Keefer, N J, Roberts
Publikováno v:
The Journal of infectious diseases. 166(2)
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) gp160 recombinant vaccinia virus (HIVAC-1e) vaccine was evaluated in vaccinia-naive, healthy adults at low risk for acquiring HIV-1 infection. Volunteers (n = 36) were ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7208e117b45c730231b38b4cb865a1b
https://pubmed.ncbi.nlm.nih.gov/1353102
https://pubmed.ncbi.nlm.nih.gov/1353102
Autor:
Victoria Perkis, Albert Z. Kapikian, Mark C. Steinhoff, K Midthun, Mary Lou Clements, Ruth A. Karron, Mary Jett-Goheen, James King, Barbara J. Burns, Roberta Samorodin, Neal A. Halsey, Modena E. H. Wilson
Publikováno v:
The Journal of infectious diseases. 164(4)
Rotavirus vaccine strain M37 (serotype 1), recovered from the stool of an asymptomatic newborn infant and serially passaged in cell culture, was given orally to adults, children, and infants. Serologic responses were detected by neutralization assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a024874616e18a55a6f40b2ddd4502e
https://pubmed.ncbi.nlm.nih.gov/1654365
https://pubmed.ncbi.nlm.nih.gov/1654365
Autor:
R, Dolin, B S, Graham, S B, Greenberg, C O, Tacket, R B, Belshe, K, Midthun, M L, Clements, G J, Gorse, B W, Horgan, R L, Atmar
Publikováno v:
Annals of internal medicine. 114(2)
To evaluate the safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant envelope glycoprotein (rgp 160) candidate vaccine in humans.Healthy adults (72) who were seronegative for HIV-1 were randomly assigned to one of fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::079fc3d81bdd7f8701a0b30e8b98513d
https://pubmed.ncbi.nlm.nih.gov/1984386
https://pubmed.ncbi.nlm.nih.gov/1984386